+ T cells mediate long-term immunity to chronic infection and cancer and respond potently to immune checkpoint blockade. These cells share transcriptional regulators with memory precursor cells, including T cell-specific transcription factor 1 (TCF1), but it is unclear whether they adopt distinct programs to adapt to the immunosuppressive environment. By comparing the single-cell transcriptomes and epigenetic profiles of CD8 + T cells responding to acute and chronic viral infections, we found that progenitor-like CD8 + T cells became distinct from memory precursor cells before the peak of the T cell response. We discovered a coexpression gene module containing Tox that exhibited higher transcriptional activity associated with more abundant active histone marks in progenitor-like cells than memory precursor cells. Moreover, thymocyte selectionassociated high mobility group box protein TOX (TOX) promoted the persistence of antiviral CD8 + T cells and was required for the programming of progenitor-like CD8 + T cells. Thus, long-term CD8 + T cell immunity to chronic viral infection requires unique transcriptional and epigenetic programs associated with the transcription factor TOX.
U
pon acute infection or vaccination, naïve T cells first differentiate into functional effector cells, a subset of which develop into memory cells and mediate immune protection 1 . In contrast, during chronic viral infection and cancer, T cells become exhausted; this is characterized by progressive loss of T cell function and memory potential, upregulation of inhibitor receptors such as programed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and reduced proliferation 2 . In the past decade, checkpoint blockade immunotherapies directed against inhibitory receptors have achieved remarkable successes in treating cancers. Recently, the hallmarks of T cell subsets with higher potential to respond to immunotherapies have become the focus of intensive study 3 .
Effector CD8
+ T cells in acute infection are heterogeneous, comprising short-lived effector cells and memory precursor cells 4 . However, the heterogeneity of CD8 + T cells responding to chronic infection has only recently been explored. In mice chronically infected with lymphocytic choriomeningitis virus (LCMV) strain clone 13, PD-1 int CD8 + T cells, were selectively expanded after PD-1 blockade relative to the PD-1 hi subset 5 . More recently, we and others identified a CD8
+ subset during chronic LCMV infection and cancer that expresses the transcription factor T cell-specific transcription factor 1 (TCF1), which is encoded by Tcf7, and is required for long-term
CD8
+ T cell immunity and responses to checkpoint blockade [6] [7] [8] [9] [10] [11] . This progenitor-like CD8
+ subset exhibits characteristics similar to stem cells, being capable of self-renewal and repopulating the terminally exhausted TCF1 lo CD8 + subset. Differentiation of these progenitorlike CD8 + T cells is positively regulated by transcription factors TCF1, B cell lymphoma 6 protein homolog (BCL6) and E2A immunoglobulin enhancer binding factors E12/E47 (E2A), and suppressed by type I interferon (IFN), B lymphocyte-induced maturation protein 1 (Blimp-1), and interferon regulatory factor 4 (IRF4) (refs. [6] [7] [8] [9] [10] 12 ). Several known pathways that regulate progenitor-like CD8 + differentiation during chronic infection are also involved in memory T cell differentiation during acute infection [6] [7] [8] [9] [10] . However, progenitor-like CD8 + T cells probably require additional transcriptional and epigenetic programs to specifically adapt to and persist in the immunosuppressive environment of chronic infection. Population-level messenger RNA profiling of virus-specific CD8 + T cells in acute versus chronic viral infections indicates that their transcriptomes gradually diverge after the first week post-infection 13 . However, given the heterogeneity within exhausted CD8 + T cells, it is important to determine whether these differences reflect changes in the frequencies of subpopulations or distinct transcriptional programs at the single-cell level. A deeper understanding of these questions can help elucidate the establishment
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of the T cell exhaustion program and optimal treatment windows for immunotherapies.
Single-cell RNA sequencing (scRNA-seq) is a powerful tool used to identify new cell subsets and uncover transcriptional differences masked by averaging the gene expression of pooled cells 14 .
In this study, we used scRNA-seq to determine the heterogeneity of virus-specific CD8 + T cells during acute and chronic LCMV infections. Our data revealed that the transcriptional programs of virusspecific CD8
+ T cells during the two infections diverged before the peak of the CD8 + T cell response. Although both subsets expressed a Tcf7-associated gene module, progenitor-like CD8 + T cells in chronic infection distinguished themselves from memory precursor cells by their enrichment of a gene module containing Tox, encoding thymocyte selection-associated high mobility group box protein TOX (TOX), a member of the high-mobility group transcription factors 15 . Progenitor-like CD8 + T cells also showed distinct epigenomic features, exhibiting more abundant active histone markers at genes coexpressed with Tox. Moreover, TOX promoted the long-term persistence of virus-specific CD8 + T cells during chronic LCMV infection. Conversely, TOX deficiency led to loss of progenitor-like CD8
+ T cells and impaired persistence of antiviral CD8 + T cells. Our results suggest that TOX endows CD8 + T cells with longevity that facilitates long-term antiviral CD8
+ immunity during chronic infection.
Results
Heterogeneity of antiviral CD8
+ T cells in chronic infection. In this study, we used scRNA-seq to perform an unbiased analysis of antiviral CD8 + T cells during chronic infection. We adoptively transferred naïve P14 CD8 + T cells, which express a transgene that encodes a T cell antigen receptor that recognizes H-2D b presenting the GP33-41 epitope 16 , into C57BL/6 recipients. Mice were then infected with LCMV clone 13, which causes chronic infection 17 . On day 7 post-infection, splenic P14 CD8 + T cells were isolated ( Supplementary Fig. 1a ) and analyzed by scRNA-seq (10× Genomics). T-distributed stochastic neighbor embedding (t-SNE) and unsupervised graph-based clustering partitioned cells into four clusters based on their transcriptomes 18 ( Fig. 1a and Supplementary  Fig. 1b ). Among the top 126 genes upregulated in cluster 3 (Supplementary Table 1) were Tcf7, Id3 and Slamf6 (encoding lymphocyte antigen 108 (Ly108)), known markers of progenitorlike CD8 + T cells 6 (Fig. 1b) . In addition, cells in cluster 3 exhibited high expression of Tox, Ikzf2 and Hif1a, and low expression of Id2, Gzma, Gzmb, Cxcr6 and Lgals3 (Fig. 1c,d and Supplementary  Fig. 1c,d ). Based on its transcriptional signature, cluster 3 most probably represents the progenitor-like CD8 + population. To determine how cells in cluster 3 overlap with progenitor-like cells at a single-cell transcriptomic level, we performed a single-cell gene enrichment analysis using 207 progenitor-like signature genes identified previously (Supplementary Table 2) 6 . Almost all cells in cluster 3 showed enrichment of progenitor-like signature genes, whereas few cells from other clusters showed enrichment (Fig. 1e ). This conclusion was independently confirmed by using a published method (AUCell 1.2.4) 19 ( Supplementary Fig. 1e ). To model the gradual changes in transcriptomes during cell differentiation, we used pseudotime analysis to plot gene expression profiles along two principle components of variance 20 ( Fig. 1f, left) . The value of principle component 2 positively correlated with Tcf7 expression (Supplementary Fig. 1f ) and enrichment of a progenitor-like gene signature (Fig. 1f, right) . This finding suggested the association of principle component 2 with the transition between progenitor-like CD8
+ T cells and their terminally exhausted counterparts. Principle component 1 probably reflects cell cycle progression through the G1-S-G2M phases ( Supplementary Fig. 1g ). Whereas cells in clusters 0 and 3, both with high component 1 values, were mostly in the G1 phase, cells in cluster 1 were mostly in the G2M or S phase (Supplementary Fig. 1h ). Thus, our results suggest that progenitor-like CD8 + T cells (cluster 3) might first undergo terminal differentiation and then commence proliferation.
CD8
+ T cell transcriptomes in acute and chronic infections diverge early. Given the heterogeneity of antiviral CD8 + T cells responding to acute and chronic infections, we used scRNA-seq to compare their transcriptional programs and the timing when the bifurcation occurs. We collected P14 CD8 + T cells from days 4.5 and 7 after infection by an acute (Armstrong) or chronic (clone 13) LCMV strain (hereafter referred to as day 4.5 Arm, day 4.5 Cl13, day 7 Arm and day 7 Cl13) for both scRNA-seq and bulk RNA-seq. Day 4.5 and 7 represent the antiviral CD8
+ responses at the mid-phase or near the peak of initial expansion, respectively. We performed the scRNA-seq experiments twice and observed strong correlations between replicates ( Supplementary Fig. 2a,b) . In addition, scRNAseq data and bulk RNA-seq data from the same condition were highly correlated ( Supplementary Fig. 2b ). To avoid batch effects, scRNA-seq data from one experiment were pooled for downstream analyses. P14 cells were transcriptionally more active with higher numbers of detected mRNA molecules and genes on day 4.5 than day 7 after infection ( Supplementary Fig. 2c ).
Using t-SNE analysis, we found that whereas day 4.5 Arm and day 4.5 Cl13 CD8
+ T cells commingled and generally occupied the same area, day 7 Arm and day 7 Cl13 CD8 + T cells were partitioned into distinct areas (Fig. 2a) . Thus, transcriptional programs between CD8 + T cells responding to acute infection versus chronic infection diverged before the peak of initial expansion. Furthermore, the differences between day 7 Arm and day 7 Cl13 CD8 + T cells reflected distinct transcriptomes at a single-cell level, not merely changes in the frequencies of subpopulations. The expression patterns of top differentially expressed genes confirmed that differential programming of antiviral CD8 + T cells responding to acute and chronic viral infections began between day 4.5 and day 7 post-infection (Fig. 2b) . Gene ontology analysis revealed that genes involved in translation were upregulated on day 7 Cl13 CD8 + T cells ( Supplementary Fig. 2d ). As expected, day 7 Arm CD8 + T cells upregulated genes related to T cell activation and killer cell cytotoxicity ( Supplementary Fig. 2e ).
We then used an unsupervised approach to assign virus-specific CD8 + T cells to different clusters based on their transcriptional profiles. We identified 11 clusters, including 6 (1, 3, 4, 5, 7, 9) from both day 4.5 samples, 4 (2, 6, 7, 8) from day 7 Arm cells and two (0, 10) unique to day 7 Cl13 cells ( Fig. 2c) . Cluster 7 included cells from day 4.5 Arm, day 4.5 Cl13 and day 7 Arm. Cells in this cluster exhibited elevated expression of type I and type II interferon gene signatures and a transcriptional signature of memory precursor cells, including upregulation of Bcl2, Ccr7, Id3, Sell and Tcf7, and downregulation of Ccr2, Gzmb, Id2, Klrg1 and Zeb2 (Fig. 2d-f and Supplementary Fig. 2f ). These data suggest that the memory precursor cell fate was established in a subset of antiviral CD8 + T cells by day 4.5 post-infection. Upregulation of Bcl2, Id3 and Tcf7 was also observed in cluster 5 (day 4.5 Arm and day 4.5 Cl13) and cluster 10 (day 7 Cl13). In addition, high expression of Mt1 encoding metallothionein-1, which promotes T cell dysfunction during cancer 21 , was found in cluster 4 (day 4.5 Arm and day 4.5 Cl13) and cluster 0 (day 7 Cl13). It was not present in cluster 10 (day 7 Cl13), which is enriched for hypoxia response genes (Fig. 2e,f and Supplementary  Fig. 2f ). Of note, clusters 10 and 0 correspond to TCF1 hi progenitorlike and TCF1 lo terminally exhausted CD8 + T cells during chronic viral infection, respectively. Thus, single-cell transcriptomes of progenitor-like and memory precursor cells diverged by day 7 postinfection despite similar expression of signature genes such as Tcf7.
TOX distinguishes progenitor-like from memory precursor cells.
Given their similarities, it is unclear whether the transcriptional program of progenitor-like CD8 + T cells is distinct from that of memory precursor cells. Although the progenitor-like signature previously identified 6 was enriched in most progenitor-like cells (cluster 10), it was also enriched in approximately 60% of cluster 7 cells, a subset with memory precursor cell characteristics, and in approximately 30% of cluster 5 cells (Fig. 3a and Supplementary Fig. 3a) . The memory precursor gene signature (Supplementary 
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Fig. 1 | Heterogeneity of virus-specific CD8
+ T cells from chronic LCMV infection delineated by scRNA-seq. a-f, Naïve P14 CD8 + T cell were transferred to C57BL/6 mice that were subsequently infected with LCMV clone 13. P14 cells were isolated on day 7 post-infection. N = 2,597 cells were used for the scRNA-seq analyses. a, The t-SNE projection of P14 cells, determined by Seurat v.2. Each dot corresponds to one individual cell. A total of four clusters (clusters 0-3) were identified and color-coded. b, Heatmap of the top 10 genes expressed in each cluster as defined in Fig. 1a . The columns correspond to the cells; the rows correspond to the genes. Cells are grouped by clusters. The color scale is based on a z-score distribution from −2 (purple) to 2 (yellow). c, Volcano plot showing the differentially expressed genes between cells within cluster 3 and cells outside cluster 3 (purple: upregulated in cluster 3; gray: downregulated in cluster 3). The x axis represents the log fold changes; the y axis presents the −log 10 adjusted P values. A two-sided Wilcoxon rank-sum test was used. d, Single-cell transcript levels of Tcf7, Tox, Gzmb, Birc5 and Top2a illustrated in the t-SNE plots. Transcript levels are color-coded: gray, not expressed; purple, expressed. e, Left panel: enrichment (log 2 P values) of progenitor-like gene signature in each cell, determined by a one-sided Fisher's exact test, illustrated in the violin plot. Cells are separated into the four clusters defined in Fig. 1a . The violin represents the probability density at each value; each dot represents one cell. failed to distinguish progenitor-like cells from memory precursor cells ( Supplementary Fig. 3b ). Thus, we sought to identify genes that were differentially expressed between progenitor-like CD8 + T cells in chronic infection (cluster 10) and other CD8 + populations that expressed Tcf7 (clusters 5 and 7). Among the top genes upregulated in cluster 10 were the ribosomal genes, Cd200, Pdcd4 and Tox ( Fig. 3b-d ). Tox encodes a transcription factor that regulates the development of CD4 + T cells and innate lymphocytes 22, 23 . Our results that Tox and Tcf7 were coexpressed in progenitor-like CD8 + T cells but not memory precursor cells indicate that these two genes might be involved in two separate gene regulatory circuits. Thus, we used coexpression network analysis of our scRNA-seq data to identify modules of coexpressed genes. Forty-nine modules were identified and color-coded, including a module containing genes such as Tcf7, Tnfsf8 and Id3 (module 29, saddlebrown) and a separate module containing Tox (module 12, tan) (Fig. 3e, Supplementary  Fig. 3c and Supplementary Tables 4 and 5 ). Based on a previous study that identified TOX binding sites in effector CD8 + T cells using chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) 24 , we identified 90 of the 200 genes in the Tox module as potential direct targets of TOX. Next, we determined the enrichment of each gene module in individual cells. Module 29 exhibited strong enrichment in cells from cluster 5, 7 and 10, similar to the Tcf7 expression pattern (Fig. 3f and Supplementary Fig. 3d ), whereas most cells with enrichment of module 12 fell in cluster 10 ( Fig. 3g and Supplementary Fig. 3e ). To confirm these findings, we isolated day 7 Cl13 progenitor-like (TIM3 Fig. 3f,g ). Consistent with the scRNA-seq data, Tox was most abundantly expressed in day 7 Cl13 progenitor-like cells ( Supplementary  Fig. 3h ). Terminally exhausted T cells also expressed Tox, albeit at lower levels than progenitor-like cells. Differential expression of TOX protein was confirmed by flow cytometric analysis ( Supplementary   Fig. 3i,j) . Thus, high expression of Tox and its associated module distinguishes progenitor-like CD8 + T cells responding to chronic viral infection from memory precursor cells.
Progenitor-like CD8
+ T cells display a distinct epigenome. Epigenomic programming is critical for the differentiation of T cells [25] [26] [27] . In this study, we used ChIP-seq to characterize the genome-wide profiles of histone H3 lysine 27 acetylation (H3K27ac), a marker of active enhancers 28 , in day 7 Cl13 progenitor-like, day 7 Cl13 terminally exhausted, day 7 Arm memory precursor and day 7 Arm short-lived effector P14 cells. Progenitor-like CD8 + T cells had the highest number of unique peaks among all four cell types ( Fig. 4a and Supplementary Fig. 4a,b) . Compared to common peaks, peaks not shared by all cell types (that is, variable peaks) were enriched in intergenic regions or introns and reduced in promoters ( Fig. 4b and Supplementary Fig. 4c ). This finding suggests that the differentiation of virus-specific CD8 + T cells is more likely to be impacted by differential activity of enhancers versus promoters. Hierarchical clustering analysis and a heatmap of these H3K27ac profiles showed that progenitor-like CD8 + T cells were most distant from the other three cell types (Fig. 4c,d ). Hierarchical clustering of scRNA-seq data also placed progenitor-like CD8
+ T cells (cluster 10) on the most distant branch (Supplementary Fig. 4d ). + T cells. The number of peaks in each category is indicated. b, Pie charts demonstrating the distribution of common or variable H3K27ac peaks across the genome (3′ untranslated region (UTR), 5′ UTR, exon, intergenic, intron, non-coding, promoter-TSS and transcription termination site (TTS)). c, Hierarchical clustering of progenitor-like, terminally exhausted, memory precursor and short-lived effector cells based on their H3K27ac profiles. d, Deposition of H3K27ac centered on variable peaks (±4 kb) in progenitor-like, terminally exhausted, memory precursor and short-lived effector CD8 + T cells. Each row represents a peak. Red represents higher signal intensity; blue represents lower signal intensity.
Next, we measured H3K27ac modification of genes coexpressed with Tox and found greater H3K27ac modification in progenitorlike CD8
+ T cells than in memory precursor cells (Fig. 5a, left) . In addition, genes with TOX binding sites 24 exhibited greater H3K27ac in progenitor-like CD8 + T cells than in memory precursor cells (Fig. 5a, right) . Moreover, progenitor-like and terminally exhausted signature genes (Supplementary Tables 2 and 6 ) exhibited higher H3K27ac abundance in their respective CD8 + populations ( Supplementary Fig. 4e,f) . We also compared H3K27ac content and mRNA levels between progenitor-like and terminally exhausted cells or between progenitor-like and memory precursor cells (Fig. 5b) . In each case, genes upregulated in progenitor-like CD8 + T cells were often associated with one or more differentially modified peaks with increased H3K27ac (fold change >1.5, false discovery rate (FDR) <0.1), whereas genes downregulated in progenitor-like cells often contained peaks with significantly less H3K27ac (Fig. 5b) .
Then, we examined the H3K27ac profiles at individual gene loci that encode the markers of the four cell types. H3K27ac peaks were found at the transcription start site (TSS) and −30-kb enhancer 29 of Tcf7 in memory precursor and progenitor-like CD8 + T cells, but not in short-lived effector or terminally exhausted CD8 + T cells (Fig. 5c ). Klrg1 was associated with more H3K27ac peaks in short-lived effector and terminally exhausted CD8 + T cells than in memory precursor and progenitor-like CD8 + T cells (Fig. 5d ). Compared to other CD8
+ subsets, progenitor-like CD8 + T cells displayed fewer H3K27ac peaks at the upstream regulatory elements of Gzmb (Fig. 5e ) and lacked an H3K27ac peak 3′ of Id2 ( Supplementary  Fig. 4g ). In contrast, there were multiple intronic H3K27ac peaks at the Tox locus that were unique and/or significantly enriched (for example, +50, +122 and +133 kb) in progenitor-like CD8 + T cells (Fig. 5f ). Based on published ChIP-seq data, several potential transcriptional regulators of CD8 + T cells during chronic infection, including nuclear factor of activated T-cells, cytoplasmic 2 (NFAT1), IRF4, runt-related transcription factor 3 (RUNX3), forkhead box protein O1 (FOXO1), signal transducer and activator of transcription 3 (STAT3) and signal transducer and activator of transcription 5B (STAT5B) (refs. 12, [30] [31] [32] [33] ), bind to the Tox locus ( Supplementary  Fig. 4h ). To determine whether the calcineurin-NFAT pathway upregulates Tox in virus-specific CD8 + T cells during chronic infection, we treated mice that were infected with LCMV clone 13 with calcineurin inhibitor FK506 (tacrolimus) starting from day 4 postinfection. On day 7 post-infection, blocking the calcineurin-NFAT pathway resulted in reduced TOX protein in virus-specific CD8 + T cells, confirming that the calcineurin-NFAT pathway positively regulates TOX expression (Supplementary Fig. 4i ).
TOX promotes persistence of virus-specific CD8
+ T cells. The pathways that endow progenitor-like CD8 + T cells with longevity in the face of immunosuppressive environments, such as chronic infection, remain unclear. To test whether TOX enhances the 
persistence of virus-specific CD8 + T cells during chronic infection, we overexpressed TOX in P14 CD8
+ T cells by retroviral transduction ( Supplementary Fig. 5a,b) and transferred transduced cells into C57BL/6 mice, which were immediately infected with LCMV clone 13. TOX overexpression greatly increased the number and frequency of splenic P14 cells on day 14 and day 28 post-infection (Fig. 6a,b) but did not affect the initial expansion of P14 cells (Fig. 6a,b) or the frequency of TCF1 hi cells (Fig. 6c and Supplementary Fig. 5c ). Thus, TOX overexpression enhanced the persistence of virus-specific CD8 + T cells without skewing their differentiation toward progenitor-like cells. Next, we sorted control and TOX-overexpressing TIM3 hi (TCF1 lo terminally exhausted) P14 CD8 + T cells on day 7 post-infection ( Supplementary Fig. 5d ) and transferred them into infection-matched mice. On day 5 post-transfer, significantly more TOX-overexpressing P14 cells were present than control cells, although both groups remained committed to the TCF1 lo lineage (Fig. 6d and Supplementary Fig. 5e ). These data suggest that ectopic expression of TOX is sufficient to endow terminally exhausted CD8
+ T cells with the ability to persist during chronic viral infection.
We profiled the transcriptomes of TIM3 Fig. 5f ) from control and TOX overexpression samples. TOX overexpression led to upregulation of 266 genes and downregulation of 358 genes in progenitor-like P14 cells, and upregulation of 48 genes and downregulation of 57 genes in terminally exhausted P14 cells (fold change > 1.5, P < 0.05, FDR < 0.1) (Supplementary Tables 7 and 8 ). Among the differentially expressed genes were transcription factors (for example, Ikzf2), inhibitory receptors (for example, Pdcd1) and effector molecules (for example, Tnf) (Fig. 6e) . We confirmed that TOX overexpression moderately increased protein PD1 and T cell immunoreceptor with Ig and ITIM domains (TIGIT) protein on P14 cells on day 7 postinfection ( Supplementary Fig. 5g,h ). However, a slight decrease in leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4) level was observed in TOX-overexpressing P14 cells (Supplementary Fig. 5i ). In addition, we found reduced production of IFN-γ, tumor necrosis factor (TNF) and interleukin 2 (IL-2) by TOX-overexpressing P14 cells after restimulation on day 7 post-infection ( Supplementary Fig. 5j-m) . However, in vitro cytotoxicity of CD8 + T cells was unaffected by TOX overexpression (Supplementary Fig. 5n ).
Using gene set enrichment analysis (GSEA) to determine whether TOX governs the activity of the Tox gene module, we found that TOX overexpression upregulated the gene signature associated with this module in both progenitor-like and terminally exhausted P14 CD8 + T cells (Fig. 6f,g ). In addition, in both progenitor-like and terminally exhausted CD8 + T cells, TOX overexpression led to the upregulation of genes in the hypoxia pathway and downregulation of signatures such as oxidative phosphorylation, mTOR signaling, IFN-α response and DNA repair ( Fig. 6h and Supplementary  Fig. 5o-s) . To determine the effects of TOX overexpression on the activity of the phosphatidylinositol 3-OH kinase (PI3K)/Akt/mTOR pathway, we quantified phospho-Akt (S473) and phospho-ribosome protein S6 (S235/S236) in control and TOX-overexpressing P14 cells on day 7 post-infection. Consistent with the GSEA results, TOX-overexpressing P14 cells exhibited lower PI3K/Akt/mTOR signaling than control cells (Fig. 6i,j) . Taken together, TOX overexpression promotes long-term persistence of virus-specific CD8 + T cells during chronic infection but reduces PI3K/Akt/mTOR signaling and cytokine production.
Progenitor-like cells and persistent CD8
+ immunity require TOX. To determine the cell-intrinsic role of TOX in the antiviral CD8 T cell response during chronic infection, we generated mixed bone marrow chimeras. + T cells exposed to the same environment. Despite comparable frequencies of LCMV-specific cells between the wild-type and Tox −/− CD8 + compartments on day 7 after LCMV clone 13 infection ( Supplementary Fig. 6a ), frequencies of TCF1 hi TIM3 lo cells were significantly lower in Tox −/− LCMV-specific CD8 + T cells than in their wild-type counterparts in the same mice (Fig. 7a,b) . This finding suggests that progenitor-like CD8
+ T cells require cellintrinsic TOX activity. To confirm these findings, we adoptively transferred CD45. lo virus-specific CD8 + T cells without impacting the magnitude of the initial expansion ( Supplementary  Fig. 6b,c) .
Next, we analyzed pooled scRNA-seq data from 4,409 wild-type and 5,296 Tox −/− LCMV-specific CD8 + T cells from mixed bone marrow chimeras on day 7 after LCMV clone 13 infection. Significant portions of wild-type and Tox −/− cells occupied distinct spaces in the t-SNE plots, suggesting that Tox deficiency led to a substantial change in the differentiation program of virus-specific CD8 + T cells (Fig. 7c) . Unsupervised clustering assigned cells into four subsets. Fewer cluster 2 cells, which expressed high levels of Tcf7, Id3 and Slamf6 and represent the progenitor-like population, were present among Tox −/− cells (Fig. 7d,e) . In addition, more cluster 0 cells, which expressed signature genes typical of terminally exhausted cells, were present in Tox −/− cells. However, Tox −/− cells in cluster 0 did not fully comingle with wild-type cells in the same cluster, suggesting that Tox deficiency altered the differentiation of terminally exhausted cells (Fig. 7c,d) . Indeed, Tox −/− cells upregulated Klrg1, which is typically associated with short-lived effectors during acute infection (Fig. 7f) (Fig. 7g,h ). Therefore, cell-intrinsic TOX activity is required both for the programming of progenitor-like CD8 + T cells and long-term CD8 + immunity during chronic viral infection. 
Discussion
Progenitor-like CD8 + T cells found in chronic viral infection and cancer have attracted great attention as a potential target for adoptive cell therapies and checkpoint blockade therapies [6] [7] [8] [9] [10] [11] [36] [37] [38] [39] [40] . However, it is unclear whether progenitor-like CD8 + T cells require distinct transcriptional and epigenetic programs to persist in the immunosuppressive environment induced by chronic viral infection and cancer. In our study, we revealed distinct transcriptional and epigenetic programs of progenitor-like CD8 + T cells in chronic infection using scRNA-seq and H3K27ac ChIP-seq. Compared to memory precursor cells in acute infection, progenitor-like cells exhibited a greater transcriptional activity and higher H3K27ac in a gene module containing Tox, identified through our scRNA-seq analyses. We further demonstrated the critical role of TOX in the persistence of antiviral CD8
+ T cells and differentiation of progenitor-like CD8 + T cells during chronic viral infection. Progenitor-like CD8 + T cells are exposed to continuous antigen stimulation and immunosuppression during chronic infection 41 . Therefore, compared to memory precursor cells, progenitor-like CD8 + T cells probably exhibit differential activities in the pathways required for the adaptation to chronic viral infection. Previous studies mostly relied on bulk transcriptomic analysis of progenitorlike CD8
+ T cells, which reflect the populational average and are affected by the bias introduced by the markers selected to purify this population. Using single-cell transcriptomes of virus-specific CD8 + T cells from mice after acute and chronic viral infections, we found that Tcf7 + CD8 + T cells from day 7 acute and chronic LCMV infections partitioned in separate areas in the t-SNE plot. This finding suggests that memory precursor and progenitor-like cells have distinct transcriptional programs despite sharing common markers. For example, we found pronounced upregulation of gene signatures, such as translation and hypoxia, in progenitor-like CD8 + T cells relative to memory precursor cells. Progenitor-like CD8 + T and memory precursor cells also differed in their H3K27ac profiles, suggesting that their differentiation might be regulated by activation of different sets of enhancers. Nonetheless, while intriguing, the epigenomic data in this study suffer from similar limitations of population-level profiles as discussed earlier. Thus, future studies that employ single-cell epigenomics might help further elucidate the differential regulation of progenitor-like CD8 + T and memory precursor cells.
Long-term persistence is a cardinal hallmark of T cell stemness and is critical for the CD8 + T cell response against chronic infection and cancer 42, 43 . Moreover, the longevity of therapeutic T cells directly affects the efficacy of adoptive cell therapies 44 . Thus, it is important to determine the molecular mechanisms underlying the longevity of progenitor-like CD8 + T cells. We found that Tox was among the most differentially expressed genes between progenitorlike CD8 + T and memory precursor cells and is in a gene module most highly expressed by progenitor-like CD8 + T cells. Consistent with our results, a previous study that used microarrays to compare the transcriptomes between CD8 + T cells responding to acute and chronic LCMV infections identified Tox as a hub gene in the difference network between acute and chronic infections 13 . In this study, we have shown that Tox deficiency led to defects in the long-term persistence of antiviral CD8
+ T cells and a loss of progenitor-like CD8 + T cells, and that TOX overexpression enhanced the persistence of both progenitor-like and terminally exhausted virusspecific CD8 + T cells. In addition, our comparison of single-cell transcriptomes between wild-type and Tox-deficient antiviral CD8 + T cells underlines a critical role of TOX in dictating the transcriptional program of virus-specific CD8 T cells responding to chronic infection. These findings suggest that TOX plays an essential role in promoting persistence of T cells in chronic infection and might promote the persistence of therapeutic T cells in immunotherapies. Interestingly, a recent study has shown that TOX is required for the pathogenicity of autoreactive CD8 + T cells in the brain 24 . Similar to our observation in chronic viral infection, Tox-deficient autoreactive CD8 + T cells downregulated Tcf7 and upregulated short-lived effector markers such as Gzmb and Klrg1. These data suggest a potential overlap of the molecular circuit involving TOX between autoreactive and antiviral CD8 + T cells. Of note, although less prevalent, some terminally exhausted CD8 + T cells expressed Tox and/or were enriched with the Tox module. Moreover, Tox deficiency also altered the differentiation program of terminally exhausted CD8 + T cells, suggesting a role of TOX in these cells. Whether progenitorlike cells directly give rise to TOX-expressing terminally exhausted cells remains to be investigated.
In summary, through scRNA-seq and H3K27ac profiling, we found that progenitor-like CD8 + T cells responding to chronic viral infection are regulated by distinct transcriptional and epigenetic programs despite their similarities with memory precursor cells. Importantly, this includes upregulation of Tox, which promotes persistent antiviral CD8 + T cell response and is necessary for progenitor-like CD8 + T cell differentiation. Our study adds to our understanding of T cell stemness and may shed new light on the development of more effective immunotherapies.
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Methods
Mice, infection, adoptive transfer, mixed bone marrow chimeras and FK506 treatment. C57BL/6 and wild-type CD45.1 (B6.SJL-Ptprca Pepcb/BoyJ) mice were purchased from the The Jackson Laboratory. P14 mice carry a transgenic T cell antigen receptor that recognizes H-2D b GP33-41 epitope on LCMV 16 . Blimp-1-yellow fluorescent protein (YFP) reporter mice 45 , purchased from The Jackson Laboratory, were bred to P14 to generate P14 Blimp-1-YFP mice. Tox-deficient mice were generated by deleting the first exon and promoter region using CRISPRCas9. Tox loxP/loxP mice have been described previously 22 and were crossed to CD4-Cre and P14 mice. All mice were kept on a C57BL/6 background. Mice used in the experiments were age-and sex-matched. All animal husbandry and experiments were approved by the National Human Genome Research Institute (NHGRI) or the National Institute of Neurological Disorders and Stroke Animal Care and Use Committees (protocols G98-3 and 1295-12).
For acute viral infections, mice were injected intravenously with 2 × 10 5 plaqueforming units LCMV Armstrong. For chronic viral infections, mice were injected intravenously with 2 × 10 6 plaque-forming units LCMV clone 13. For the adoptive transfer experiments, 5,000 naïve splenic P14 cells were adoptively transferred into mice before infection. To generate the mixed bone marrow chimeras, lethally irradiated (950 rad) wild-type mice were reconstituted with 1:1 mixed bone marrows from CD45.1 and CD45.2 donors that were either wild-type or Toxdeficient. After at least two months from the date of reconstitution, chimeras were used for the experiments. For the FK506 treatment, 10 mg kg −1 FK506 were injected subcutaneously into mice daily from day 4 to day 7 post-infection, as described previously 46 .
Retroviral transduction.
The TOX (UniProt ID: Q66JW3-1) overexpression construct was made with a murine stem cell virus-internal ribosome entry sitegreen fluorescent protein (MSCV-IRES-GFP) backbone (pMIG) as described previously 29 . Activated P14 CD8
+ T cells were spinoculated with retroviruses carrying a control (pMIG) or a TOX overexpression construct for 90 min, cultured overnight with 2 ng ml −1 IL-7 and sorted by flow cytometry for GFP + -transduced P14 cells. Five thousand GFP + P14 cells were injected into each C57BL/6 recipient, which was immediately infected with LCMV clone 13. b GP33-41 tetramer was obtained from the National Institute of Allergy and Infectious Diseases Tetramer Core Facility. TCF1 staining has been described in our previous study 29 . BD LSR II and BD FACSAria II (BD Biosciences) were used for the flow cytometry analysis and fluorescenceactivated cell sorting (FACS) sorting, respectively. Data analysis was performed with FlowJo v.9.9 (FlowJo LLC).
scRNA-seq. The scRNA-seq libraries were generated using Chromium Single Cell 3′ Library & Gel Bead Kit v.2 (10x Genomics) according to the manufacturer's protocol. Briefly, 1-1.5 × 10 4 live cells were FACS-sorted and used to generate single-cell gel-beads in emulsion. After reverse transcription, gel-beads in emulsion were disrupted. Barcoded complementary DNA was isolated and amplified by PCR (12 cycles). Following fragmentation, end repair and A-tailing, sample indexes were added during index PCR (8 cycles). The purified libraries were sequenced on a HiSeq 3000 (Illumina) with 26 cycles of read 1, 8 cycles of i7 index and 98 cycles of read 2.
scRNA-seq analysis. Alignment, filtering, barcode counting and unique molecular identifier counting were performed using Cell Ranger v.2.1.0. Data were further analyzed using Seurat v.2 (ref. 47 ). Briefly, cells with a percentage of mitochondrial genes below 0.05% were included. Cells with the highest (top 0.2%) or lowest (bottom 0.2%) numbers of detected genes were considered as outliers and excluded from the downstream analyses. Raw unique molecular identifier counts were normalized to unique molecular identifier count per million total counts and log-transformed. Variable genes were selected based on average expression and dispersion. Principal component analysis was performed using variable genes. Clusters and t-SNE plots were generated based on selected principal component analysis dimensions. Marker genes were identified by the Seurat function FindAllMarkers. Scaled expression data of these marker genes were used for creating the heatmaps. Normalized data are shown in the form of feature plots or violin plots. Gene set enrichment was performed on each cell by calculating the P values of a Fisher's exact test to determine the enrichment of a gene set in each cell.
Alternatively, cells with active gene sets were identified using AUCell 1.2.4, as described previously 19 . Trajectory analysis was performed with Monocle v.2 (ref. 20 ). Gene ontology analysis was performed using maker genes in Metascape 3.0 (ref. + T cell population were collected. DNA-protein crosslinking, nuclei isolation and chromatin sonication were performed using the truChIP Chromatin Shearing Kit (Covaris) according to the manufacturer's instructions. After immunoprecipitation by anti-H3K27ac antibody (catalog no. ab4729; AbCam), ChIPmentation was performed according to the published protocol 50 . The libraries were sequenced for 50 cycles (single read) on a HiSeq 3000.
ChIP-seq analysis. ChIP-seq reads were mapped to the mouse genome (build mm10) with Bowtie v.1.1.1 (ref. 51 ). Peaks were identified using model-based analysis for ChIP-seq (MACS v.1.4.2; default P value threshold of 1 × 10 −5 ) (ref.
52
). Only peaks identified in both biological replicates were selected for downstream analysis. Peak annotation was performed with the Hypergeometric Optimization of Motif EnRichment (HOMER) program v.4.9 (ref. 53 ). Peaks were visualized in the Integrative Genomics Viewer. To determine differentially modified H3K27ac peaks between different CD8 + subsets, reads per peak were calculated by HOMER. Statistically differentially modified peaks were then determined using edgeR v.20.9, defined as those with an FDR (Benjamini-Hochberg) < 0.1 and a fold change > 1.5.
RNA-seq.
For each biological replicate, cells from at least three mice were pooled; 5 × 10 4 cells were sorted and resuspended in QIAzol lysis reagent (QIAGEN). Total RNA was extracted with the miRNeasy Mini Kit (QIAGEN). mRNA was selected using the NEBNext Poly(A) mRNA Magnetic Isolation Module (New England Biolabs). RNA-seq libraries were generated with the NEBNext Ultra RNA Library Prep Kit for Illumina (New England Biolabs) and NEBNext Multiplex Oligos for Illumina (New England Biolabs) according to the manufacturer's instructions. The libraries were sequenced on a HiSeq 3000 with 50 cycles of single reads.
RNA-seq analysis. RNA-seq reads were mapped to the mouse genome (mm10) using TopHat v.2.1.0 (ref. 54 ). Normalization to reads per kilobase of transcript per million mapped reads (RPKM) and analysis of variance statistical analyses were performed with the Partek Genomics Suite analysis software v.6.6. Differentially expressed genes were selected using the following criteria: P < 0.05, FDR < 0.1, fold change > 1.5 and expression > 4 RPKM in at least one condition. To compare the bulk RNA-seq data with the scRNA-seq data, bulk RNA-seq transcripts per kilobase million were calculated by pseudo-aligning RNA-seq reads to Ensembl transcript sequences using kallisto v.0.44.0. ClusterProfiler 3.8.1 was used for the GSEA analysis 55 .
FACS-based in vitro killing assay. EL4 cells were labeled with the CellTrace Violet Proliferation Kit (Thermo Fisher Scientific), pulsed with GP33 peptide at 1 μg ml −1 for 1 h at 37 °C and used as target cells. In vitro activated control or TOXoverexpressing CD8 + T cells were collected and incubated with peptide-pulsed EL4 cells at different ratios for 4 h at 37 °C. The percentages of dead EL4 cells were measured with the LIVE/DEAD Fixable Aqua Dead Cell Stain Kit.
Statistical analysis. Statistical analyses were conducted with R v.3.4.0 and Prism 6 (GraphPad Software). Pearson's r was calculated with the R function cor(). Unless otherwise stated, a two-tailed paired or unpaired Student's t-test was used to determine statistical significance (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001). The mean and s.d. are presented in the figures. The error bars represent the s.d.
